Novavax Inc
NVAX
ISIN null / Valor 47862952
Novavax Inc
UMushroom community rating:
About company
Novavax Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Leveraging proprietary recombinant nanoparticle vaccine technology, Novavax has been at the forefront of developing vaccines for a range of infectious diseases, including its notable efforts in creating a vaccine for COVID-19. The company's approach combines the power of genetic engineering and nanoparticle technology to produce vaccine candidates aimed at eliciting robust immune responses. While the company has gained significant attention for its work during the COVID-19 pandemic, its research and development efforts extend to other infectious diseases as well, positioning Novavax as a key player in the global effort to combat emerging health threats through vaccination.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
1679 M
Market cap (USD)
4,652,960
Daily traded volume (Shares)
8.2 / 7.7
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Nicolas Allet
Réka Vass
Robin Roten
EQUITIES OF THE SAME SECTOR
